Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions

Human Pathology

Volumn 28, Issue 3, 1997, Pages 309-315

  Nakamura, Toshitsugu ^a   Nomura, Setsuo ^b   Sakai, Toshihiko ^b   Nariya, Shoji ^b  

^a Suwa Red Cross Hospital   (Japan)

^b NONE

Author keywords

adenocarcinoma; apoptosis; bcl 2 protein; immunohistochemistry; premalignant lesion

Indexed keywords

ONCOPROTEIN;

ADENOCARCINOMA; ADENOMA; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; ENDOMETRIUM; GASTROINTESTINAL CARCINOMA; GASTROINTESTINAL TRACT; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; PRECANCER; PROTEIN EXPRESSION; REGULATORY MECHANISM; UTERINE CERVIX; UTERUS; UTERUS CARCINOMA;

EID: 0031050873     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90129-5     Document Type: Article

References (28)

1. Korsmeyer SJ: bcl-1 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992
2. Chen-Levy Z, Nourse J, Cleary ML: The bcl-2 candidate protooncogene product is a 24 kilodalton integral membrane protein expressed in lymphoid cell lines and lymphomas carrying the t(14:18) translocation. Mol Cell Biol 9:701-710, 1989
3. Seto M, Jaeger U, Hockett RD, et al: Alternative promotors in exons, somatic mutation and deregulation of the bcl-2-lg fusion gene in lymphoma. EMBO J 7:123-131, 1988
4. Hockenbery DM, Zutter M, Hickey W, et al: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88:6961-6965, 1991
5. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metast Rev 11:95-103, 1992
6. Nakamura T, Sakai T, Nariya S: Cell death in colorectal polyps as evaluated by in situ 3′-tailing reaction and its relation with BCL-2 expression. Pathol Int 45:721-728, 1995
7. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31-49, 1965
8. Hirota T, Itabashi M, Suzuki K, et al: Clinicopathologic study of minute and small early gastric cancer: Histogenesis of gastric cancer. Pathol Annu 15:1-19, 1980
9. Morson BC, Sobin LH, Grundmann E, et al: Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 33:711-721, 1980
10. Nakamura K, Kino I: Histopathology of the Gastrointestinal Tract: Biopsy Interpretation. Tokyo, Igaku Shoin, 1980, pp 65-79
11. World Health Organization: Histological typing of female genital tract tumors. International Histological Classification of Tumours, Berlin, Springer-Verlag, 1994
12. Shi S-R, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748, 1991
13. Umemura S, Kawai K, Osamura RY, et al: Antigen retrieval for bcl-2 protein in formalin-fixed, paraffin-embedded sections. Pathol Int 45:103-107, 1995
14. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
15. Bosari S, Moneghini L, Graziani D, et al: bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. HUM PATHOL 26:534-540, 1995
16. Bronner MP, Culin C, Reed JC, et al: The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146:20-26, 1995
17. Gauwesky CE, Hoxie J, Vomell PC, et al: Pre-B-cell leukemia with a t(8;14) and a t(14;18) translocation is preceded by follicular lymphoma. Oncogene 2:431-435, 1988
18. Ochiai A: Genetic alteration in gastric cancer and precancerous lesion. Pathol Clin Med 13:107-111, 1995
19. Lauwers GY, Scott GV, Hendricks J: Immunohistochemical evidence of bcl-2 protein expression in gastric epithelial dysplasia. Cancer 73:2900-2904, 1994
20. Lauwers GY, Scott GV, Karpeh MS: Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 75:2209-2213, 1995
21. Boddington MM, Spriggs AI, Codwell RH: Adenocarcinoma of the uterine cervix: Cytological evidence of a long preclinical evolution. Br J Obstet Gynaecol 83:900-903, 1978
22. Scully RE: Definition of endometrial carcinoma precursors. Clin Obstet Gynecol 25:39-48, 1982
23. Scheffner M, Munger K, Byrne JC, et al: The state of the p53 and retinoblastoma gene in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A 88:5523-5527, 1991
24. Scheffner M, Werness BA, Huibregtse JM, et al: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136, 1990
25. Shaw P, Bovey R, Tardy S, et al: Induction of apoptosis by wild type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A 89:4495-4499, 1992
26. Pezzella F, Turkey H, Kuzu I, et al: bcl-2 protein in nonsmall cell lung carcinoma. N Engl J Med 329:690-694, 1993
27. Doglioni C, Deitos AP, Laurino L, et al: The prevalence of Bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch 424:45-51, 1994
28. Viale G, Roncalli M, Grimelius L, et al: Prognostic value of Bcl-2 immunoreactivity in medullary thyroid carcinoma. HUM PATHOL 26:945-950, 1995